107 related articles for article (PubMed ID: 4016778)
1. Phase II study of mitolactol in advanced malignant melanoma.
Murray N; Silver H; Shah A; Wilson K
Cancer Treat Rep; 1985 Jun; 69(6):723-4. PubMed ID: 4016778
[No Abstract] [Full Text] [Related]
2. Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma.
Creagan ET; Ahmann DL; Schutt AJ; Green SJ
Cancer Treat Rep; 1982 Jun; 66(6):1425-6. PubMed ID: 7083244
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of mitolactol in patients with metastatic melanoma.
Medina W; Kirkwood JM
Cancer Treat Rep; 1982 Jan; 66(1):195-6. PubMed ID: 7053257
[No Abstract] [Full Text] [Related]
4. Phase II study of mitolactol in metastatic malignant melanoma.
Simmonds MA; Lipton A; Harvey HA; Ellison N; White DS
Cancer Treat Rep; 1985 Jan; 69(1):65-7. PubMed ID: 3967260
[TBL] [Abstract][Full Text] [Related]
5. Mitolactol chemotherapy for malignant melanoma: a phase II study.
Malden LT; Coates AS; Milton GW; McCarthy WH; Levi JA; Woods RL; Byrne MJ; Reynolds PM; Fox RM; Hedley DW
Cancer Treat Rep; 1984; 68(7-8):1045-6. PubMed ID: 6744338
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of tamoxifen in patients with metastatic malignant melanoma.
Telhaug R; Klepp O; Børmer O
Cancer Treat Rep; 1982 Jun; 66(6):1437. PubMed ID: 7083247
[No Abstract] [Full Text] [Related]
7. Phase II trial of tamoxifen in malignant melanoma.
Leichman CG; Samson MK; Baker LH
Cancer Treat Rep; 1982 Jun; 66(6):1447. PubMed ID: 7083248
[No Abstract] [Full Text] [Related]
8. Phase II study of an aziridinylbenzoquinone (AZQ) in disseminated malignant melanoma.
Creagan ET; Schutt AJ; Ahmann DL; Green SJ
Cancer Treat Rep; 1982 Dec; 66(12):2089-90. PubMed ID: 7139650
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of 4'-epi-doxorubicin in patients with advanced malignant melanoma.
Berman E; Casper ES; Howard J; Wittes RE
Cancer Treat Rep; 1984 Apr; 68(4):679-80. PubMed ID: 6585272
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of i.v. menogaril in patients with malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group Study.
McCulloch PB; Eisenhauer EA; Shibata HR; Young VP
Cancer Treat Rep; 1987; 71(7-8):771-2. PubMed ID: 2955887
[No Abstract] [Full Text] [Related]
11. Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma.
Richman SP; Woodcock TM; Kubota TT; Blumenreich MS; Gentile PS; Allegra JC
Cancer Treat Rep; 1984 Nov; 68(11):1395-6. PubMed ID: 6209008
[No Abstract] [Full Text] [Related]
12. Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma.
Lopez M; Di Lauro L; Papaldo P; Ganzina F; Di Pietro N; Lazzaro B
Cancer Treat Rep; 1986 Jul; 70(7):911-2. PubMed ID: 3459575
[No Abstract] [Full Text] [Related]
13. Cis-diamminedichloroplatinum in the treatment of disseminated malignant melanoma.
Mechl Z; Krejcí P
Neoplasma; 1983; 30(3):371-7. PubMed ID: 6683360
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen in the treatment of metastatic malignant melanoma.
Wagstaff J; Thatcher N; Rankin E; Crowther D
Cancer Treat Rep; 1982 Sep; 66(9):1771. PubMed ID: 7116353
[No Abstract] [Full Text] [Related]
15. Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma.
Legha SS; Hall SW; Powell KC; Burgess MA; Benjamin RS; Gutterman JU; Bodey GP
Cancer Clin Trials; 1980; 3(2):111-4. PubMed ID: 6893573
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of mitomycin in disseminated malignant melanoma.
Creagan ET; Edmonson JH; Ahmann DL; Chang M
Cancer Treat Rep; 1985 Dec; 69(12):1451-2. PubMed ID: 4075321
[No Abstract] [Full Text] [Related]
17. Phase I--II study of hexamethylmelamine plus dibromodulcitol in refractory carcinoma of the breast.
Van Amburg AL; Presant CA; Vélez-García E; Klahr C
Cancer Treat Rep; 1979 Jan; 63(1):141-2. PubMed ID: 105806
[No Abstract] [Full Text] [Related]
18. Phase II study of mitolactol in chemotherapy-refractory metastatic breast cancer.
Creech RH; Catalano RB; Dierks KM; Shah MK
Cancer Treat Rep; 1984 Dec; 68(12):1499-501. PubMed ID: 6548936
[TBL] [Abstract][Full Text] [Related]
19. Vindesine for metastatic malignant melanoma. A phase II trial.
Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
[TBL] [Abstract][Full Text] [Related]
20. Phase II evaluation of spirogermanium in malignant melanoma: a Southwest Oncology Group Study.
Goodwin JW; Kopecky K; Slavik M; Tranum BL; Balcerzak SP; Fletcher WS; Costanzi JJ
Cancer Treat Rep; 1987 Oct; 71(10):985-6. PubMed ID: 3652061
[No Abstract] [Full Text] [Related]
[Next] [New Search]
